🇺🇸 FDA
Pipeline program

Intraarterial infusion of autologous bone marrow cells

CMMo/ICPD/2008

Phase 2 other completed

Quick answer

Intraarterial infusion of autologous bone marrow cells for Critical Limb Ischemia (CLI) is a Phase 2 program (other) at Design Therapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Critical Limb Ischemia (CLI)
Phase
Phase 2
Modality
other
Status
completed

Clinical trials